Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · IEX Real-Time Price · USD
13.88
+0.85 (6.52%)
At close: Mar 28, 2024, 4:00 PM
13.90
+0.02 (0.16%)
After-hours: Mar 28, 2024, 7:45 PM EDT
Inovio Pharmaceuticals Market Cap
Inovio Pharmaceuticals has a market cap or net worth of $304.52 million as of March 28, 2024. Its market cap has increased by 12.58% in one year.
Market Cap
304.52M
Enterprise Value
189.43M
1-Year Change
12.58%
Ranking
Category
Stock Price
$13.88
Market Cap Chart
Since March 31, 1999, Inovio Pharmaceuticals's market cap has increased from $71.80M to $304.52M, an increase of 324.12%. That is a compound annual growth rate of 5.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 304.50M | 5.25% |
Mar 26, 2024 | 289.30M | -0.17% |
Mar 25, 2024 | 289.80M | 6.70% |
Mar 22, 2024 | 271.60M | 5.85% |
Mar 21, 2024 | 256.60M | 1.74% |
Mar 20, 2024 | 252.20M | 1.04% |
Mar 19, 2024 | 249.60M | -0.36% |
Mar 18, 2024 | 250.50M | -0.16% |
Mar 15, 2024 | 250.90M | -0.67% |
Mar 14, 2024 | 252.60M | -3.92% |
Mar 13, 2024 | 262.90M | -2.27% |
Mar 12, 2024 | 269.00M | -4.41% |
Mar 11, 2024 | 281.40M | 18.28% |
Mar 8, 2024 | 237.90M | 12.75% |
Mar 7, 2024 | 211.00M | -8.54% |
Mar 6, 2024 | 230.70M | 4.77% |
Mar 5, 2024 | 220.20M | -1.43% |
Mar 4, 2024 | 223.40M | 2.81% |
Mar 1, 2024 | 217.30M | 7.79% |
Feb 29, 2024 | 201.60M | 4.73% |
Feb 28, 2024 | 192.50M | -6.19% |
Feb 27, 2024 | 205.20M | 10.56% |
Feb 26, 2024 | 185.60M | 3.63% |
Feb 23, 2024 | 179.10M | 2.75% |
Feb 22, 2024 | 174.30M | -2.90% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cerus | 314.65M |
Sanara MedTech | 313.79M |
Nanobiotix | 310.08M |
Sera Prognostics | 308.04M |
Sharecare | 304.95M |
Adverum Biotechnologies | 303.44M |
Immutep | 303.05M |
Senseonics Holdings | 300.68M |